Click for best price
Chronic Kidney Disease Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 11200 million
|
Forecast Market size by 2030 |
US$ 12620 million
|
| Growth Rate |
CAGR of 1.7% |
Number of Pages |
76 Pages |
The global Chronic Kidney Disease Drugs market was valued at US$ 11200 million in 2022 and is projected to reach US$ 12620 million by 2030, at a CAGR of 1.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease Drugs. This report contains market size and forecasts of Chronic Kidney Disease Drugs in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
ACE Inhibitors Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Kidney Disease Drugs include Keryx Biopharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, AbbVie, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche Ltd, Pfizer, AstraZeneca and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Kidney Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Kidney Disease Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, by Type, 2022 (%)
- ACE Inhibitors
- Calcium Channel Blockers
- Beta Blockers
- Others
Global Chronic Kidney Disease Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Specialty Clinics
Global Chronic Kidney Disease Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Chronic Kidney Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Kidney Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chronic Kidney Disease Drugs revenues share in global market, 2022 (%)
Key companies Chronic Kidney Disease Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Chronic Kidney Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Keryx Biopharmaceuticals, Inc
- Kissei Pharmaceutical Co., Ltd
- AbbVie
- GlaxoSmithKline
- Sanofi
- F. Hoffmann-La Roche Ltd
- Pfizer
- AstraZeneca
- Amgen
- Teva Pharmaceutical Industries
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Chronic Kidney Disease Drugs, market overview.
- Chapter 2: Global Chronic Kidney Disease Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of Chronic Kidney Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Chronic Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Chronic Kidney Disease Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chronic Kidney Disease Drugs Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 11200 million
|
| Forecast Market size by 2030 |
US$ 12620 million
|
| Growth Rate |
CAGR of 1.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
76 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Kidney Disease Drugs Overall Market Size
2.1 Global Chronic Kidney Disease Drugs Market Size: 2022 VS 2030
2.2 Global Chronic Kidney Disease Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Chronic Kidney Disease Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Chronic Kidney Disease Drugs Players in Global Market
3.2 Top Global Chronic Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Chronic Kidney Disease Drugs Revenue by Companies
3.4 Global Chronic Kidney Disease Drugs Sales by Companies
3.5 Global Chronic Kidney Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Kidney Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Kidney Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Kidney Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Kidney Disease Drugs Market Size Markets, 2022 & 2030
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blockers
4.1.4 Beta Blockers
4.1.5 Others
4.2 By Type - Global Chronic Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Kidney Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chronic Kidney Disease Drugs Revenue, 2024-2030
4.2.3 By Type - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Chronic Kidney Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Chronic Kidney Disease Drugs Sales, 2018-2023
4.3.2 By Type - Global Chronic Kidney Disease Drugs Sales, 2024-2030
4.3.3 By Type - Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Kidney Disease Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Chronic Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Kidney Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chronic Kidney Disease Drugs Revenue, 2024-2030
5.2.3 By Application - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Chronic Kidney Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Chronic Kidney Disease Drugs Sales, 2018-2023
5.3.2 By Application - Global Chronic Kidney Disease Drugs Sales, 2024-2030
5.3.3 By Application - Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Chronic Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Chronic Kidney Disease Drugs Market Size, 2022 & 2030
6.2 By Region - Global Chronic Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Kidney Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chronic Kidney Disease Drugs Revenue, 2024-2030
6.2.3 By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Chronic Kidney Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Chronic Kidney Disease Drugs Sales, 2018-2023
6.3.2 By Region - Global Chronic Kidney Disease Drugs Sales, 2024-2030
6.3.3 By Region - Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Chronic Kidney Disease Drugs Revenue, 2018-2030
6.4.2 By Country - North America Chronic Kidney Disease Drugs Sales, 2018-2030
6.4.3 US Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.4 Canada Chronic Kidney Disease Drugs Market Size, 2018-2030
6.4.5 Mexico Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Chronic Kidney Disease Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Chronic Kidney Disease Drugs Sales, 2018-2030
6.5.3 Germany Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.4 France Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.5 U.K. Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.6 Italy Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.7 Russia Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Chronic Kidney Disease Drugs Market Size, 2018-2030
6.5.9 Benelux Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Chronic Kidney Disease Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Chronic Kidney Disease Drugs Sales, 2018-2030
6.6.3 China Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6.4 Japan Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6.5 South Korea Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Chronic Kidney Disease Drugs Market Size, 2018-2030
6.6.7 India Chronic Kidney Disease Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Chronic Kidney Disease Drugs Revenue, 2018-2030
6.7.2 By Country - South America Chronic Kidney Disease Drugs Sales, 2018-2030
6.7.3 Brazil Chronic Kidney Disease Drugs Market Size, 2018-2030
6.7.4 Argentina Chronic Kidney Disease Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, 2018-2030
6.8.3 Turkey Chronic Kidney Disease Drugs Market Size, 2018-2030
6.8.4 Israel Chronic Kidney Disease Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Chronic Kidney Disease Drugs Market Size, 2018-2030
6.8.6 UAE Chronic Kidney Disease Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Keryx Biopharmaceuticals, Inc
7.1.1 Keryx Biopharmaceuticals, Inc Company Summary
7.1.2 Keryx Biopharmaceuticals, Inc Business Overview
7.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Major Product Offerings
7.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Keryx Biopharmaceuticals, Inc Key News & Latest Developments
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Chronic Kidney Disease Drugs Major Product Offerings
7.3.4 AbbVie Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Chronic Kidney Disease Drugs Major Product Offerings
7.5.4 Sanofi Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Chronic Kidney Disease Drugs Major Product Offerings
7.7.4 Pfizer Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Chronic Kidney Disease Drugs Major Product Offerings
7.8.4 AstraZeneca Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Chronic Kidney Disease Drugs Major Product Offerings
7.9.4 Amgen Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Chronic Kidney Disease Drugs Production Capacity, Analysis
8.1 Global Chronic Kidney Disease Drugs Production Capacity, 2018-2030
8.2 Chronic Kidney Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Kidney Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Kidney Disease Drugs Supply Chain Analysis
10.1 Chronic Kidney Disease Drugs Industry Value Chain
10.2 Chronic Kidney Disease Drugs Upstream Market
10.3 Chronic Kidney Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Kidney Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chronic Kidney Disease Drugs in Global Market
Table 2. Top Chronic Kidney Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chronic Kidney Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chronic Kidney Disease Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Chronic Kidney Disease Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Chronic Kidney Disease Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chronic Kidney Disease Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Chronic Kidney Disease Drugs Product Type
Table 9. List of Global Tier 1 Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Chronic Kidney Disease Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Chronic Kidney Disease Drugs Sales (K MT), 2024-2030
Table 16. By Application ? Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Chronic Kidney Disease Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Chronic Kidney Disease Drugs Sales (K MT), 2024-2030
Table 21. By Region ? Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chronic Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Chronic Kidney Disease Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Chronic Kidney Disease Drugs Sales (K MT), 2024-2030
Table 26. By Country - North America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Chronic Kidney Disease Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Chronic Kidney Disease Drugs Sales, (K MT), 2024-2030
Table 30. By Country - Europe Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Chronic Kidney Disease Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Chronic Kidney Disease Drugs Sales, (K MT), 2024-2030
Table 34. By Region - Asia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Chronic Kidney Disease Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Chronic Kidney Disease Drugs Sales, (K MT), 2024-2030
Table 38. By Country - South America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Chronic Kidney Disease Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Chronic Kidney Disease Drugs Sales, (K MT), 2024-2030
Table 42. By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales, (K MT), 2024-2030
Table 46. Keryx Biopharmaceuticals, Inc Company Summary
Table 47. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Offerings
Table 48. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Keryx Biopharmaceuticals, Inc Key News & Latest Developments
Table 50. Kissei Pharmaceutical Co., Ltd Company Summary
Table 51. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Offerings
Table 52. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Chronic Kidney Disease Drugs Product Offerings
Table 56. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Chronic Kidney Disease Drugs Product Offerings
Table 60. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Chronic Kidney Disease Drugs Product Offerings
Table 64. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Ltd Company Summary
Table 67. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Offerings
Table 68. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Chronic Kidney Disease Drugs Product Offerings
Table 72. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Chronic Kidney Disease Drugs Product Offerings
Table 76. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Amgen Company Summary
Table 79. Amgen Chronic Kidney Disease Drugs Product Offerings
Table 80. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Amgen Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Company Summary
Table 83. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Offerings
Table 84. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Teva Pharmaceutical Industries Key News & Latest Developments
Table 86. Chronic Kidney Disease Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 87. Global Chronic Kidney Disease Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Chronic Kidney Disease Drugs Production by Region, 2018-2023 (K MT)
Table 89. Global Chronic Kidney Disease Drugs Production by Region, 2024-2030 (K MT)
Table 90. Chronic Kidney Disease Drugs Market Opportunities & Trends in Global Market
Table 91. Chronic Kidney Disease Drugs Market Drivers in Global Market
Table 92. Chronic Kidney Disease Drugs Market Restraints in Global Market
Table 93. Chronic Kidney Disease Drugs Raw Materials
Table 94. Chronic Kidney Disease Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Chronic Kidney Disease Drugs Downstream
Table 96. Chronic Kidney Disease Drugs Downstream Clients in Global Market
Table 97. Chronic Kidney Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Kidney Disease Drugs Segment by Type in 2022
Figure 2. Chronic Kidney Disease Drugs Segment by Application in 2022
Figure 3. Global Chronic Kidney Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Kidney Disease Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Chronic Kidney Disease Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Chronic Kidney Disease Drugs Sales in Global Market: 2018-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Kidney Disease Drugs Revenue in 2022
Figure 9. By Type - Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Chronic Kidney Disease Drugs Price (USD/MT), 2018-2030
Figure 13. By Application - Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Chronic Kidney Disease Drugs Price (USD/MT), 2018-2030
Figure 17. By Region - Global Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 23. US Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 28. Germany Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 37. China Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Chronic Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Chronic Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Chronic Kidney Disease Drugs Production Capacity (K MT), 2018-2030
Figure 53. The Percentage of Production Chronic Kidney Disease Drugs by Region, 2022 VS 2030
Figure 54. Chronic Kidney Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
